WO2025247982 - PIPERAZINES WHICH ACT AS SSTR4 MODULATORS
National phase entry is expected:
Publication Number
WO/2025/247982
Publication Date
04.12.2025
International Application No.
PCT/EP2025/064805
International Filing Date
28.05.2025
Title **
[English]
PIPERAZINES WHICH ACT AS SSTR4 MODULATORS
[French]
PIPÉRAZINES AGISSANT EN TANT QUE MODULATEURS DE SSTR4
Applicants **
GRÜNENTHAL GMBH
Inventors
PEIL, Sebastian
NORDHOFF, Sonja
DIALER, Clemens
PETTERSSON, Martin
Priority Data
24178741.5
29.05.2024
EP
63/652,755
29.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5822 | |
| EPO | Filing, Examination, Granting | 125509 | |
| Japan | Filing, Examination, Granting | 5015 | |
| South Korea | Filing, Examination, Granting | 8572 | |
| USA | Filing, Examination, Granting | 30390 |
Total:
175,308
Abstract[English]
The present invention relates to compounds according to general formula (I) which are modulators of the SSTR4 receptor.[French]
La présente invention concerne des composés selon la formule générale (I) qui sont des modulateurs du récepteur SSTR4.